Sajith Wickramasekara, CEO and cofounder of Benchling, joins a16z Bio + Health partners Jorge Conde and Jay Rughani.
In this episode, a16z partners Jorge Conde and Jay Rughani sit down with Sajith Wickramasekara, CEO and cofounder of Benchling, to unpack the evolution of Benchling from idea to transformative software platform. Saji discusses his journey from software engineer to building Benchling and digitizing biotech workflows for industry giants like Sanofi. Together, they also talk about the increasing complexity of biology, the expanding role of AI in drug discovery, and the power of well-structured data.
The 21st century isn't just the century of advanced biology—it's also the era of creating tools that supercharge scientific discovery.